Open AccessThe prevalence of pulmonary embolism in non-hospitalised de-isolated patients diagnosed with mild COVID-19 disease
Author(s) -
Osayande Evbuomwan,
Gerrit Engelbrecht,
Melissa V. Bergman,
Sello Mokwena,
Oluwatosin Ayeni
Publication year - 2021
Publication title -
samj. south african medical journal/south african medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 57
eISSN - 2078-5135
pISSN - 0256-9574
DOI - 10.7196/samj.2021.v111i8.15657
Subject(s) - medicine , pulmonary embolism , interquartile range , pulmonary angiography , incidence (geometry) , radiology , retrospective cohort study , covid-19 , disease , physics , infectious disease (medical specialty) , optics
Pulmonary embolism (PE) is a known complication of COVID-19 disease. The mechanism of thromboembolic events appears to be stimulated by excessive thrombin production, inhibition of fibrinolysis and deposition of antiphospholipids and thrombi, as well as microvascular dysfunction in multiple vascular beds. The occurrence of PE has been well demonstrated in hospitalised patients with severe disease. Very few data are available on its incidence or prevalence in non-hospitalised patients diagnosed with a milder form of the disease.